Blitz Relief
Camphor, Menthol
Blitz Products Llc
Human Otc Drug
NDC 72676-101Blitz Relief also known as Camphor, Menthol is a human otc drug labeled by 'Blitz Products Llc'. National Drug Code (NDC) number for Blitz Relief is 72676-101. This drug is available in dosage form of Spray. The names of the active, medicinal ingredients in Blitz Relief drug includes Camphor (synthetic) - 4 g/100mL Menthol - 3 g/100mL . The currest status of Blitz Relief drug is Active.
Drug Information:
| Drug NDC: | 72676-101 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Blitz Relief |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Camphor, Menthol |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Blitz Products Llc |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Spray |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | CAMPHOR (SYNTHETIC) - 4 g/100mL
MENTHOL - 3 g/100mL
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 13 Nov, 2020 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 09 May, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part348 |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | BLITZ PRODUCTS LLC
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| RxCUI: | 2463934
|
| The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UPC: | 0860000473903
|
| UPC stands for Universal Product Code. |
| UNII: | 5TJD82A1ET
L7T10EIP3A
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 72676-101-11 | 29.57 mL in 1 BOTTLE, SPRAY (72676-101-11) | 13 Nov, 2020 | N/A | No |
| 72676-101-12 | 59 mL in 1 BOTTLE, SPRAY (72676-101-12) | 13 Nov, 2020 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose topical analgesic
Product Elements:
Blitz relief camphor, menthol 1,2-hexanediol arnica montana flower butylene glycol calendula officinalis flower caprylyl glycol glycerin glyceryl monostearate hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer (45000 mpa.s at 1%) lavender oil magnesium chloride peppermint oil polyoxyl 40 hydrogenated castor oil peg-100 stearate propanediol rosemary oil alcohol water menthol menthol camphor (synthetic) camphor (synthetic)
Indications and Usage:
Uses temporary relief of minor muscle and joint pain associated with strains sprains cramps arthritis
Warnings:
Warnings for external use only when using this product: use only as directed do not bandage tightly or use with a heating pad avoid contact with eyes or mucus membrane donât apply to wounds or damaged skin wash hands after use with cold water stop use and ask a doctor if: condition worsens symptoms persist for more than 7 days or clear up and occur again within a few days redness is present irritation develops if pregnant or breast-feeding: ask a health professional before use
Dosage and Administration:
Directions adults and children 10 years of age and older: shake before using spray generously to affected areas massage thoroughly to receive maximum benefit not more than 4 times a day
Package Label Principal Display Panel:
01b lbl_blitz_pain relief_2oz